Atlas Trials

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

Clinical trial NCT06557161 · RECRUITING

Trial details

NCT number
NCT06557161
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia, Adult
Start date
2025-03-01
Primary completion
2029-08-31
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.